GUJTHEM NSI Week ended 07 Aug 2026

Weekly Investor Report

Gujarat Themis Biosyn Limited · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 356.0 INR
-0.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 51.5% of its 52-week range. The latest completed week returned -0.6%, after a -6.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 50/100.

Setup score 39 out of 100
Latest Close 356.0 INR 7 Aug 2026
1W Return -0.6% latest completed week
4W Return -6.1% short-term follow-through
12W Return -3.9% quarterly tape
Trend Breadth 46.2% 24 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 34.56% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.6% Latest completed week; four-week move -6.1%. Indicator stack 46/35 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 34.56% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 25 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 51.5% of its 52-week range. The latest completed week returned -0.6%, after a -6.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6612-week average 0.56

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.66Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.1% over four weeks, -3.9% over 12 weeks, and 4.8% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W-0.6%
4W-6.1%
12W-3.9%
26W9.9%
52W4.8%
Active trend streak6 weeks
Active weeks in one year24
Trend breadth46.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.24Latest activity-pressure read.
Pressure change-137.6%Four-week change in activity pressure.
Leadership-3.34Latest relative-leadership reading.
RS change-172.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength20/100Blend of value, momentum, and quality. Underlying universe rank 81; rank 1 is best.
Value2/100Relative valuation strength. Underlying universe rank 99; rank 1 is best.
Quality69/100Profitability and accounting quality. Underlying universe rank 32; rank 1 is best.
Momentum71/100Medium-term price momentum. Underlying universe rank 30; rank 1 is best.
Growth27/100Revenue and earnings growth. Underlying universe rank 74; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework12/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
83.2x
Price divided by trailing earnings.
Price / sales
23.4x
Market value relative to trailing revenue.
EV / EBITDA
51.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-3.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
83.4%
Gross profit retained from each unit of revenue.
Operating margin
37.8%
Operating profit retained from revenue.
Free-cash-flow margin
-74.6%
Free cash flow generated from revenue.
Return on invested capital
10.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.0%
Latest one-year revenue growth.
EPS growth
-4.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.2%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 25 relevant articles.

1 positive · 24 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-25.7%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+13.7%Week of 10 Apr.
Worst week-8.2%Week of 27 Feb.
Latest week-0.6%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains3
Flat weeks0
Modest losses12
Sharp losses5
Recent vol4.0%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew5.7% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape40/100

Trend, activity pressure, participation, and risk combine to a 40/100 tape read.

 Indicator analysis68/100

Latest 12-week confirmation: trend 6/12, activity pressure 11/12, relative leadership 10/12.

Activity pressure 0.66; No reversal markers Next-Week ExpectancyNegative 34.56%

Next-week expectancy is negative with a 34.56% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors39/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 35; Small Cap Core rank 98 SVQF12/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 1380.0 of 1576 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 25 relevant articles.

Sachin D. Patel acquires 5.2 lakh Gujarat Themis Biosyn shares Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026356.0 INR-0.6%343.0 INR350.7 INR-0.24-3.34838.8KOn
31 Jul 2026358.0 INR-0.7%344.2 INR350.6 INR0.01-1.96137.6KOn
24 Jul 2026360.5 INR-2.5%346.7 INR350.5 INR0.301.21224.9KOn
17 Jul 2026369.6 INR-2.5%349.5 INR350.4 INR0.521.42365.9KOn
10 Jul 2026379.0 INR-1.8%350.7 INR350.1 INR0.624.61395.7KOn
3 Jul 2026386.0 INR-1.9%351.0 INR349.7 INR0.646.53120.4KOn
26 Jun 2026393.5 INR2.6%350.7 INR349.2 INR0.689.890Off
19 Jun 2026383.5 INR-1.0%351.2 INR348.6 INR0.777.68165.5KOff
12 Jun 2026387.3 INR-6.3%352.2 INR348.1 INR0.7911.0085.3KOff
5 Jun 2026413.2 INR2.2%354.2 INR347.5 INR0.8020.17137.7KOff
29 May 2026404.3 INR9.7%355.4 INR346.5 INR0.8317.414.2MOff
22 May 2026368.7 INR-0.4%357.4 INR345.6 INR0.796.97621.5KOff
15 May 2026370.3 INR-7.1%360.2 INR345.2 INR0.808.27373.5KOff
8 May 2026398.5 INR9.6%362.3 INR344.8 INR0.5214.26943.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context